Julia Mellentin-Michelotti
Papers
1
Total Citations
67
H-Index
1
About
Julia Mellentin-Michelotti has made foundational contributions to high-throughput screening (HTS) and assay miniaturization, particularly through her pioneering work on fluorometric microvolume assay technology (FMAT). Her most-cited paper, "Homogeneous Cell- and Bead-Based Assays for High Throughput Screening Using Fluorometric Microvolume Assay Technology" (1999, 67 citations), introduced a novel platform that enabled sensitive, homogeneous detection in both cell-based and bead-based formats—a critical advancement for drug discovery. This work demonstrated how FMAT could streamline HTS by eliminating wash steps and reducing reagent consumption, directly impacting the efficiency of pharmaceutical screening pipelines. Mellentin-Michelotti’s research sits at the intersection of analytical chemistry, cell biology, and assay development, with a focus on creating robust, scalable methods for measuring molecular interactions and cellular responses. Her contributions have been cited by researchers developing next-generation screening technologies, underscoring her role in shaping modern HTS practices. By bridging the gap between traditional plate-based assays and emerging miniaturized formats, she helped lay the groundwork for more rapid, cost-effective drug discovery processes.
Research Focus
Key Achievements
Top Papers
- 1